Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Supply of Rituximab (MabThera) Vial 1400 MG/11.7 ML to NHS Scotland.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Roche Products Ltd | 00100674 | - | 1 lot Lot 1 | LOBBYIST M&F Health (5 quarters) Ovid Consulting Ltd (2 quarters) |
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Awarded To | Status |
|---|---|---|---|
| Lot 1 | £2,404,041 initial term | Roche Products Ltd | active |
Government spending data: This supplier has received £151,897,283 in 2,207 payments (over £25k) from Department of Health and Social Care, Manchester University NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust, Guy's and St Thomas' NHS FT, United Lincolnshire Hospitals NHS Trust and 12 more public bodies (2019-10-17 to 2026-03-31). View full payment history →